Substitution of Generic Drugs and Biosimilars-Reply.
Sarpatwari A, Kesselheim AS, Sacks CA.
JAMA Intern Med. 2021 Apr 01. 181(4):568. PMID: 33492341
Assistant Professor
Ameet Sarpatwari
Assistant Professor in the Department of Health Policy and Management
Health Policy and Management
Other Positions
Assistant Professor of Medicine
Medicine
Brigham and Women's Hospital
Links
Bibliography
Frequency of First Generic Drug Approvals With "Skinny Labels" in the United States.
Walsh BS, Sarpatwari A, Rome BN, Kesselheim AS.
JAMA Intern Med. 2021 Mar 29. PMID: 33779681
Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions.
Sacks CA, Van de Wiele VL, Fulchino LA, Patel L, Kesselheim AS, Sarpatwari A.
JAMA Intern Med. 2021 Jan 01. 181(1):16-22. PMID: 32865564
Corrections to Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions.
Sarpatwari A.
JAMA Intern Med. 2021 Jan 01. 181(1):144. PMID: 33252639
Preventing medical-device-borne outbreaks: High-level disinfection policy for duodenoscopes.
Mehrotra P, Weber DJ, Sarpatwari A.
Infect Control Hosp Epidemiol. 2021 Mar. 42(3):334-337. PMID: 33308347
Generic Competition for Drugs Treating Rare Diseases.
Beall RF, Quinn AE, Kesselheim AS, Tessema FA, Sarpatwari A.
J Law Med Ethics. 2020 12. 48(4):789-795. PMID: 33404340
Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) Program.
Sarpatwari A, He M, Tessema FA, Gagne JJ, Kesselheim AS.
Drug Saf. 2021 Mar. 44(3):327-335. PMID: 33206339
A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways.
Druedahl LC, Almarsdóttir AB, Kälvemark Sporrong S, De Bruin ML, Hoogland H, Minssen T, van de Weert M, Kesselheim AS, Sarpatwari A.
Nat Biotechnol. 2020 11. 38(11):1253-1256. PMID: 33144720
Ensuring Safe Access to Mifepristone During the Pandemic and Beyond.
Brown BL, Wood SF, Sarpatwari A.
Ann Intern Med. 2021 01. 174(1):105-106. PMID: 33085508
Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation?
Sarpatwari A, Avorn J, Kesselheim AS.
BMJ. 2020 10 08. 371:m3841. PMID: 33032982